top of page

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...
JMG Logo transparent.png
Executive Spotlights

Axonis Therapeutics Secures $115M Series A to Advance Neuromedicine Pipeline

Boston, MA, October 30, 2024 (PRNewswire) -- Axonis Therapeutics raised $115 million in Series A funding to advance AXN-027 for epilepsy and pain treatment. Axonis will advance its oral KCC2 pipeline to treat neurological conditions.


Read full article here.

Recent Posts

See All

Comments


Life Science Headlines
bottom of page